Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Change in Account Payables: 2009-2024

Historic Change in Account Payables for Avadel Pharmaceuticals (AVDL) over the last 16 years, with Dec 2024 value amounting to -$4.1 million.

  • Avadel Pharmaceuticals' Change in Account Payables rose 92.22% to $8.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$3.1 million, marking a year-over-year decrease of 173.44%. This contributed to the annual value of -$4.1 million for FY2024, which is 364.92% down from last year.
  • Avadel Pharmaceuticals' Change in Account Payables amounted to -$4.1 million in FY2024, which was down 364.92% from $1.5 million recorded in FY2023.
  • Avadel Pharmaceuticals' 5-year Change in Account Payables high stood at $4.2 million for FY2021, and its period low was -$4.1 million during FY2024.
  • In the last 3 years, Avadel Pharmaceuticals' Change in Account Payables had a median value of -$3.1 million in 2022 and averaged -$1.9 million.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Change in Account Payables spiked by 251.79% in 2021 and then plummeted by 364.92% in 2024.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Change in Account Payables stood at -$2.8 million in 2020, then surged by 251.79% to $4.2 million in 2021, then tumbled by 173.44% to -$3.1 million in 2022, then surged by 149.71% to $1.5 million in 2023, then slumped by 364.92% to -$4.1 million in 2024.